Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

The Efficacy and Cost-Effectiveness of Behavioral Counseling for Exercise in Men and Women Following Acute Myocardial Infarction (AMI) and Percutaneous Coronary Intervention (PCI)

5 de noviembre de 2010 actualizado por: Ottawa Heart Institute Research Corporation

Efficacy and Cost-Effectiveness of Behavioral Counseling For Exercise Behavior in Men and Women Following AMI and PCI

Purpose: The purpose of this project is to determine how effective the telephone-based counseling program is at helping patients with heart disease become more physically active.

Hypotheses to be tested:

  • Compared to usual care, patients in the physical activity counseling program will:

    1. significantly increase total distance measured by an accelerometer and minutes of physical activity at a moderate intensity or higher,
    2. have significantly higher generic and heart-disease health-related quality of life, and
    3. will lead to greater improvements in the mediators of behavior change (psychosocial variables, i.e. self-efficacy, outcome expectations, etc.) at 26 and 52 weeks;
  • Changes in the mediators of physical activity will predict changes in physical activity outcomes at 26 and 52 weeks;
  • The physical activity counseling program is preferable to usual care from the perspective of health care system costs.

Descripción general del estudio

Descripción detallada

Most existing cardiac rehabilitation programs have little ability to expand participation using traditional delivery models that emphasize supervised, facility-based programs. Furthermore, facility-based programs to promote physical activity behavior in patients with coronary artery disease (CAD) are limited in their impact because most patients are unwilling to travel more than 30-45 minutes to participate in a program. The University of Ottawa Heart Institute Prevention and Rehabilitation Centre (Ottawa, Canada) has developed a telephone-based counseling program, specifically to support heart patients in becoming more physically active. The study will involve patients either participating in a 12-month physical activity counseling (PAC) program, or receiving usual care after they are discharged from hospital. For patients assigned to the PAC group, a face-to-face meeting with a physical activity counselor will occur within 10 days to 2 weeks after being discharged from hospital. At this time the patient will be provided with a personalized physical activity program which will be tailored based on prior activity levels, clinical history, and recovery. The PAC patients will also receive eight telephone-based counseling sessions at 2, 4, 8, 14, 20 and 24 weeks, and 2 telephone maintenance contacts at 40 and 52 weeks after hospital discharge. Each telephone call is scheduled to last 10-15 minutes. For patients assigned to the usual care (UC) group, they will receive the physical activity advice and care usually provided to patients discharged from hospital. Following hospitalization, usual care typically includes a follow-up visit(s) with your cardiologist and/or family doctor. If requested, an activity program will be provided to usual care group participants after the study has finished. In addition, the patients will also be required to complete five research questionnaires, and two telephone interviews. The study will track all participants for a period of one year from the time they are discharged from hospital. Over the next twelve months 252 patients from the Ottawa Heart Institute are expected to take part in the study.

Tipo de estudio

Intervencionista

Inscripción (Anticipado)

304

Fase

  • Fase 1

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

    • Ontario
      • Ottawa, Ontario, Canadá, K1Y 4W7
        • University of Ottawa Heart Institute

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

20 años a 85 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Cardiac Diagnosis:

    1) hospitalized patients ready for discharge following successful PCI procedure

  • Including patients receiving PCI following admission for AMI or hospitalized post-AMI patients who have not been revascularized
  • No lesions with >50 % stenosis
  • English proficiency in reading, writing and speaking
  • Age: 20-85 years

Exclusion Criteria:

  • Those patients who are already taking part in another research trial.
  • Patient intends to enroll, or is currently enrolled in structured cardiac rehabilitation
  • Unable to participate in the on-site cardiac supervised rehab program, cardiac rehab lite, case-managed home cardiac rehab program, Pembroke cardiac rehab program
  • Hospitalization for coronary artery bypass (CABG)
  • Chronic obstructive pulmonary disease (COPD)
  • Hospitalization for diagnostic procedure not associated with previously documented MI
  • Patient coming back to hospital for planned staged PCI within 6 months
  • Cardiac transplantation
  • Presence of, or hospitalization for defibrillator implant
  • Hospitalization for pacemaker implantation
  • Unresolved unstable angina and/or hospitalization for angina (without MI or PCI)
  • Uncontrolled arrhythmias causing symptoms or hemodynamic compromise
  • Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
  • Other uncontrolled metabolic conditions (e.g. diabetes)
  • Chronic infectious diseases such as mononucleosis, hepatitis, AIDS
  • Acute systemic illness or fever
  • Uncontrolled tachycardia (<120 bpm)
  • Uncompensated congestive heart failure (and/or NYHA Class III, or IV)
  • 3rd degree atrioventricular (AV) block (without pacemaker)
  • Active pericarditis or myocarditis
  • Recent embolism
  • Suspected or known abdominal aortic aneurysm (AAA) > 4cm
  • Uncontrolled hypertension (systolic blood pressure [SBP] >200; diastolic blood pressure [DBP] >110)
  • Pregnancy

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
7-day physical activity levels: waist mounted pedometer will be worn to measure distance (km) over a period of 9 days and will be recorded in an activity log, as well as, reported intensity and duration of activities at a moderate level+
7-day physical activity recall (PAR): interview administered following the pedometer wear to verify the completeness of the patient recorded activity log and to account for leisure and occupational/domestic activities
Primary outcomes measured at baseline and 6 and 12 months

Medidas de resultado secundarias

Medida de resultado
Psychosocial and Environmental Mediators (questionnaire): psychosocial and environmental mediators of physical activity
Quality of Life (questionnaire): heart disease health-related quality of life
generic quality of life
secondary outcomes measured at baseline and 6 and 12 months
Health Care Systems Costs (questionnaire and telephone): the costs of in-person and telephone-based behavioral counseling sessions and any additional health care relating to coronary artery disease (CAD)
the use of health care resources will be measured for medical event updates, patient related costs and work absenteeism
cost utility analysis to assess for cost per quality-adjusted life year (QALY)
measured at 3 (telephone), 6 (questionnaire), 9 (telephone) and 12 (questionnaire) months

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Robert Reid, PhD, MBA, Ottawa Heart Institute Research Corporation
  • Silla de estudio: Louise Morrin, RPT, MBA, Ottawa Heart Institute Research Corporation
  • Silla de estudio: Lyall Higginson, MD, FRCP(C), Ottawa Heart Institute Research Corporation
  • Silla de estudio: Andrew Pipe, MD, The University of Ottawa Heart Institute
  • Silla de estudio: Andreas Wielgosz, MD, FRCP(C), The Ottawa General Hospital - Department of Cadiology - General Campus
  • Silla de estudio: Neil Oldridge, PhD, College of Health Sciences, University of Wisconsin-Milwaukee
  • Silla de estudio: George Wells, PhD, Clinical Epidemiology Unit, University of Ottawa Heart Institute
  • Silla de estudio: Chris Blanchard, PhD, Department of Human Kinetics, University of Ottawa & University of Ottawa Heart Institute

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de agosto de 2005

Finalización primaria (Actual)

1 de diciembre de 2009

Finalización del estudio (Actual)

1 de diciembre de 2009

Fechas de registro del estudio

Enviado por primera vez

7 de noviembre de 2005

Primero enviado que cumplió con los criterios de control de calidad

7 de noviembre de 2005

Publicado por primera vez (Estimar)

8 de noviembre de 2005

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

9 de noviembre de 2010

Última actualización enviada que cumplió con los criterios de control de calidad

5 de noviembre de 2010

Última verificación

1 de noviembre de 2010

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

3
Suscribir